1. Home
  2. CRBP vs MAXN Comparison

CRBP vs MAXN Comparison

Compare CRBP & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBP
  • MAXN
  • Stock Information
  • Founded
  • CRBP 2009
  • MAXN 2019
  • Country
  • CRBP United States
  • MAXN Singapore
  • Employees
  • CRBP N/A
  • MAXN N/A
  • Industry
  • CRBP Biotechnology: Pharmaceutical Preparations
  • MAXN Semiconductors
  • Sector
  • CRBP Health Care
  • MAXN Technology
  • Exchange
  • CRBP Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • CRBP 103.6M
  • MAXN 101.1M
  • IPO Year
  • CRBP N/A
  • MAXN N/A
  • Fundamental
  • Price
  • CRBP $8.18
  • MAXN $5.22
  • Analyst Decision
  • CRBP Strong Buy
  • MAXN Sell
  • Analyst Count
  • CRBP 8
  • MAXN 6
  • Target Price
  • CRBP $61.38
  • MAXN $195.80
  • AVG Volume (30 Days)
  • CRBP 291.7K
  • MAXN 249.2K
  • Earning Date
  • CRBP 03-11-2025
  • MAXN 12-05-2024
  • Dividend Yield
  • CRBP N/A
  • MAXN N/A
  • EPS Growth
  • CRBP N/A
  • MAXN N/A
  • EPS
  • CRBP N/A
  • MAXN N/A
  • Revenue
  • CRBP N/A
  • MAXN $689,010,000.00
  • Revenue This Year
  • CRBP N/A
  • MAXN N/A
  • Revenue Next Year
  • CRBP N/A
  • MAXN $34.68
  • P/E Ratio
  • CRBP N/A
  • MAXN N/A
  • Revenue Growth
  • CRBP N/A
  • MAXN N/A
  • 52 Week Low
  • CRBP $7.64
  • MAXN $4.79
  • 52 Week High
  • CRBP $61.90
  • MAXN $465.00
  • Technical
  • Relative Strength Index (RSI)
  • CRBP 35.10
  • MAXN 38.59
  • Support Level
  • CRBP $7.64
  • MAXN $5.51
  • Resistance Level
  • CRBP $9.51
  • MAXN $5.94
  • Average True Range (ATR)
  • CRBP 0.84
  • MAXN 0.42
  • MACD
  • CRBP -0.05
  • MAXN 0.05
  • Stochastic Oscillator
  • CRBP 13.71
  • MAXN 35.22

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: